Jeffrey McGroarty
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jeffrey McGroarty
Earlier roles on record: CFO at Annovis Bio, Inc. (ANVS) until September 9, 2022. Annovis Bio, Inc. reported in an 8-K filed September 12, 2022 that Jeffrey McGroarty was terminated as Chief Financial Officer, effective September 9, 2022. The proxy statement of Annovis Bio, Inc. reports total compensation of $964,259 for Jeffrey McGroarty in fiscal 2022, including a base salary of $330,257. Disclosed compensation is on record for 5 fiscal years.
“the Company is terminating Executive's employment with the Company without cause effective September 9, 2022”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2022-09-09
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Annovis Bio, Inc. (ANVS) | Former Chief Financial Officer | $330,257 | $964,259 |
| 2021 | Annovis Bio, Inc. (ANVS) | Former Chief Financial Officer | $315,000 | $4,978,184 |
| 2020 | Annovis Bio, Inc. (ANVS) | Chief Financial Officer | $300,000 | $894,232 |
| 2019 | Annovis Bio, Inc. (ANVS) | Chief Financial Officer | — | — |
| 2018 | Annovis Bio, Inc. (ANVS) | Chief Financial Officer | — | — |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.